I personally bought into CZI recently for Yarawindah and viewed WM as providing beneficial risk mitigation which I valued at 0.3-0.4x NPV. This result is at the lower bound of the range, however, I'm happy that CZI keep Yarawindah and I have access to the potential for free, I'll also take up any option for preference in the Caspin IPO.
I understand why long term holders would be frustrated, the deal does look on the cheap side - unless, management already know the full potential of Yarawindah and this deal is in light of that!?
CZI Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held